WCM Investment Management LLC Boosts Stock Holdings in Haleon plc (NYSE:HLN)

WCM Investment Management LLC raised its position in shares of Haleon plc (NYSE:HLN) by 97.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 313,712 shares of the company’s stock after acquiring an additional 154,947 shares during the quarter. WCM Investment Management LLC’s holdings in Haleon were worth $2,983,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC raised its stake in Haleon by 49.7% in the 3rd quarter. GAMMA Investing LLC now owns 15,043 shares of the company’s stock valued at $159,000 after purchasing an additional 4,992 shares during the last quarter. Atomi Financial Group Inc. grew its holdings in shares of Haleon by 48.3% during the third quarter. Atomi Financial Group Inc. now owns 22,518 shares of the company’s stock worth $238,000 after buying an additional 7,330 shares in the last quarter. CWM LLC raised its position in shares of Haleon by 13.6% in the third quarter. CWM LLC now owns 24,978 shares of the company’s stock valued at $264,000 after buying an additional 2,996 shares during the last quarter. Ritholtz Wealth Management purchased a new position in shares of Haleon in the third quarter worth about $275,000. Finally, Procyon Advisors LLC boosted its position in Haleon by 1.7% during the third quarter. Procyon Advisors LLC now owns 162,911 shares of the company’s stock worth $1,724,000 after acquiring an additional 2,755 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

Shares of HLN stock opened at $9.55 on Monday. The firm has a market cap of $43.21 billion, a P/E ratio of 28.07, a P/E/G ratio of 2.70 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a one year low of $7.89 and a one year high of $10.80. The firm’s 50 day moving average price is $9.53 and its 200-day moving average price is $9.79.

Analyst Ratings Changes

A number of analysts have commented on HLN shares. Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.